Leerink Partnrs Estimates Immunovant FY2030 Earnings
Immunovant, Inc. (NASDAQ:IMVT – Free Report) – Equities researchers at Leerink Partnrs issued their FY2030 EPS estimates for Immunovant in a research note issued on Thursday, May 29th. Leerink Partnrs analyst T. Smith forecasts that the company will earn $1.06 per share for the year. The consensus estimate for Immunovant’s current full-year earnings is ($2.69) […]
More Stories
Major Winter Storm to Hit US, Weather Service Warns
By Jack Phillips The National Weather Service (NWS) on Wednesday forecast that a “major January winter storm” will impact a...
Trump Right About Arctic Security, NATO’s Rutte Says
By Guy Birchall NATO Secretary-General Mark Rutte said on Jan. 21 at the World Economic Forum in Davos, Switzerland, that...
Is NetMirror Safe: Features, Pros and Cons with Top Alternatives
If you are also a movie lover like me, but don’t want to buy the subscription plans. Try NetMirror, which...
Why Greenland Is Vital for US to Counter China and Russia
By John Haughey and Autumn Spredemann U.S. President Donald Trump has said that the United States must purchase, annex, or,...
Lutnick Says US Can Hit 6 Percent Growth If Fed Cuts Rates
By Tom Ozimek Commerce Secretary Howard Lutnick said on Jan. 20 he expects the American economy to expand at an...
Supreme Court to Review Trump’s Firing of Fed Governor
By Sam Dorman Another one of President Donald Trump’s high-profile firings is headed to the Supreme Court on Jan. 21,...